Mitoxantrone

NOVANTRONE 2 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION

20 mg concentrado para solución para perfusiónSpainSuspendedAuthorised 31 May 1988

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Mitoxantrone

NOVANTRONE 2 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION

20 mg concentrado para solución para perfusiónSpainSuspendedAuthorised 31 May 1988

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

NovantroneUnited States · 20MG BASE/10ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 25MG BASE/12.5ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 2MG BASE/ML … · injectable · Serono INC

OnkotroneItaly · Concentrato per soluzione per infusione · Baxter S.P.A.

Mitoxantron Accord 2 mg/ml, concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Accord Healthcare B.V.

Mitoxantron Sandoz 2 mg/ml, concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Sandoz B.V.

ONKOTRONE 2 mg/mlRomania · 2mg/ml · conc. pt. sol. inj. · Baxter Oncology GMBH

MITOXANTRONE BAXTER INJECTION 2 mg/mlSingapore · 2 mg/ml · injection · Baxter Healthcare (Asia) Pte LTD

Mitoxantrone HydrochlorideUnited States · 20MG BASE/10ML, 25MG BASE/12.5ML, 30MG BASE/15ML · injectable · Fresenius Kabi Oncol

EvomixanBrazil · Farmarin Industria e Comercio Ltda

EvomixanBrazil · Hospira Produtos Hospitalares Ltda

Mitoxantrone InjectionCanada · 2 MG / ML · Solution · Fresenius Kabi Canada LTD

Packs

Pack	Code	Status
NOVANTRONE 2 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 10 ml	974931

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Mitoxantrone
Strength: 20 mg
Dosage form: concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Suspended
Status in the register: Suspendido
Authorised: 31 May 1988
Registration: 57408
Marketing authorisation holder: Mylan Ire Healthcare Limited
Procedure: National, MRP or DCP
Supply: Uso Hospitalario

Mitoxantrone · 2,3284 mg · concentrado para solución para perfusión

SpainWithdrawn